Abluminus DES+ - Concept Medical
Abluminus DES+ - Concept Medical - Stent Manufacturer in Surat, India
REVOLUTIONARY DES TO ADDRESS
UNMET CLINICAL NEED

ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease.

ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction.

Sirolimus Eluting

Stent System

Abluminus DES+

Envisolution Technology

  • ABLUMINAL COATING - Abluminus DES+

    ABLUMINAL COATING

    Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation

  • FUSION COATING - Abluminus DES+

    FUSION COATING

    Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis

  • Edge Coating - Abluminus DES+

    Edge Coating

    The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis

  • Biodegradable Film - Abluminus DES+

    Biodegradable Film

    The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions

TECHNICAL SPECIFICATION

Drug Polymer
Drug Sirolimus
Drug Dose 0.70µg/mm²
Drug Carrier Customized biodegradable polymer matrix
Stent
Stent Material Cobalt Chromium Alloy L605
Strut Thickness 73µm
Strut Width 80µm (hinge) – 120µm (strut)
Average Recoil Less than 5%
Average Foreshortening Less than 1% (Zero foreshortening design)
Delivery System
Delivery System RX stent delivery system
Nominal Pressure 8 bar
Rated Burst Pressure 14 bar
Guide Wire Compatibility (max.) 0.014″
Guiding Catheter Compatibility 5F
Stent Diameter (mm) 2.25, 2.50, 2.75, 3.00, 3.50, 4.00
Stent Length(mm) 8, 12, 16, 20, 24, 28, 32, 36, 40
Crossing Profile 0.038″
Entry Profile 0.016″

ORDERING INFORMATION

Stent
Diameter
Stent Length
08 mm 12 mm 16 mm 20 mm 24 mm 28 mm 32 mm 36 mm 40 mm
2.25mm EAB22508 EAB22512 EAB22516 EAB22520 EAB22524 EAB22528 EAB22532 EAB22536 EAB22540
2.50mm EAB25008 EAB25012 EAB25016 EAB25020 EAB25024 EAB25028 EAB25032 EAB25036 EAB25040
2.75mm EAB27508 EAB27512 EAB27516 EAB27520 EAB27524 EAB27528 EAB27532 EAB27536 EAB27540
3.00mm EAB30008 EAB30012 EAB30016 EAB30020 EAB30024 EAB30028 EAB30032 EAB30036 EAB30040
3.50mm EAB35008 EAB35012 EAB35016 EAB35020 EAB35024 EAB35028 EAB35032 EAB35036 EAB35040
4.00mm EAB40008 EAB40012 EAB40016 EAB40020 EAB40024 EAB40028 EAB40032 EAB40036 EAB40040
Abluminus DES+

Robust And Comprehensive Clinical Programs

MORE THAN 10,000 PATIENTS ENROLED AND PLANNED

Sr. No Study Name Type of Study Target Patients Country Principal Investigator
Sr. No:  1 Study Name:   en-ABL 1 Study Type of Study:  Prospective, Single centre, Non- randomized clinical trial Target Patients:  40 Patients Country:  India Principal Investigator:  Dr. Sameer Dani
Sr. No:  2 Study Name:   en-ABL e-REGISTRY Type of Study:  Multi-center, Prospective, All-comers registry Target Patients:  2,500 patients Country:  India Principal Investigator:  Dr. Sameer Dani
Sr. No:  3 Study Name:   Dedicate Registry Type of Study:  Prospective, Multi-center, Spontaneous clinical registry Target Patients:  5,000 patients Country:  Global Principal Investigator:  Dr. Luca Testa
Sr. No:  4 Study Name:   Ability RCT Type of Study:  Multi-centre, Single-blinded, Randomized, Investigator-initiated pilot clinical study Target Patients:  165 patients Country:  Italy Principal Investigator:  Dr. Azeem Latib,
Dr. Antonio Colombo
“Confidence Through Evidence’”
Get in Touch